XML 25 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Unearned ESOP Shares [Member]
Dow Inc. [Member]
Retained Earnings [Member]
The Dow Chemical Company
The Dow Chemical Company
Common Stock [Member]
The Dow Chemical Company
Additional Paid-in Capital [Member]
The Dow Chemical Company
Retained Earnings [Member]
The Dow Chemical Company
Accumulated Other Comprehensive Loss
The Dow Chemical Company
Unearned ESOP Shares [Member]
The Dow Chemical Company
Noncontrolling Interests
Total Equity, Beginning at Dec. 31, 2019   $ 8 $ 7,325 $ 17,045 $ (10,246) $ (91)     $ 0 $ 7,333 $ 17,313 $ (10,246) $ (91)  
Stock Issued                   53        
Stock-based compensation and allocation of ESOP shares     119     34       119     34  
Net income available for The Dow Chemical Company common stockholder $ (18)     (11)             (11)      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             $ (1,685)              
Other       10             (11)      
Other comprehensive income 305       305     $ 305       305    
Total Equity, Ending at Sep. 30, 2020 12,932 8 7,497 15,472 (9,941) (57)   13,691 0 7,505 15,606 (9,941) (57) $ 578
Total Equity, Beginning at Jun. 30, 2020   8 7,431 16,017 (10,225) (69)     0 7,439 16,147 (10,225) (69)  
Stock Issued                   23        
Stock-based compensation and allocation of ESOP shares     43     12       43     12  
Net income available for The Dow Chemical Company common stockholder (28)     (25)             (25)      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             (513)              
Other       2             (3)      
Other comprehensive income 284       284     284       284    
Total Equity, Ending at Sep. 30, 2020 12,932 8 7,497 15,472 (9,941) (57)   13,691 0 7,505 15,606 (9,941) (57) 578
The Dow Chemical Company’s stockholders’ equity 12,354             13,113            
The Dow Chemical Company’s stockholders’ equity 12,435             12,999            
Total Equity, Beginning at Dec. 31, 2020 13,005 8 7,595 16,361 (10,855) (49)   13,569 0 7,603 16,300 (10,855) (49)  
Stock Issued                   211        
Stock-based compensation and allocation of ESOP shares     182     25       182     25  
Net income available for The Dow Chemical Company common stockholder 4,552     4,575             4,576      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             (2,361)              
Other       18             (18)      
Other comprehensive income 1,190       1,190     1,190       1,190    
Total Equity, Ending at Sep. 30, 2021 17,028 8 7,988 19,357 (9,665) (24)   17,393 0 7,996 18,497 (9,665) (24) 589
Total Equity, Beginning at Jun. 30, 2021   8 7,898 18,200 (9,676) (32)     0 7,906 17,745 (9,676) (32)  
Stock Issued                   11        
Stock-based compensation and allocation of ESOP shares     79     8       79     8  
Net income available for The Dow Chemical Company common stockholder 1,675     1,683             1,679      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             $ (919)              
Other       8             (8)      
Other comprehensive income 11       11     11       11    
Total Equity, Ending at Sep. 30, 2021 17,028 $ 8 $ 7,988 $ 19,357 $ (9,665) $ (24)   17,393 $ 0 $ 7,996 $ 18,497 $ (9,665) $ (24) $ 589
The Dow Chemical Company’s stockholders’ equity $ 16,439             $ 16,804